Intervention for Sustained Testing and Retention (iSTAR) Among HIV-infected Patients
Intervention for Sustained Testing and Retention (iSTAR) Among HIV-infected Patients
批准号:
9337549
负责人:
Echezona Edozie Ezeanolue
金额:
$25.5万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-02 至 2018-03-31
关键词:
15 year oldAccountingAcquired Immunodeficiency SyndromeAddressAfrica South of the SaharaAttitudeB-LymphocytesBehaviorCaliforniaCaringCase ManagementChicagoChildChildhoodChurchClergyClimateClinicClinicalCluster randomized trialCollaborationsCommunitiesContinuity of Patient CareControl GroupsCountryDevelopmentDiagnosisEducational InterventionEffectivenessEffectiveness of InterventionsEvaluationFemale of child bearing ageFundingFunding AgencyGenerationsGenotypeGoalsHIVHIV InfectionsHIV diagnosisHealthHepatitis BHuman immunodeficiency virus testIndividualInfantInfectionInstitutionInterventionLaboratoriesLeadershipLifeLinkMaintenanceMediationMethodsMother-to-child HIV transmissionNevadaNigeriaOutcomeParticipantPathway AnalysisPatientsPerceptionPhasePolicy MakerPregnancyPregnant WomenPreparationPreventionPrevention programRandomizedResourcesRiskSickle CellSiteSocial NetworkStagingTestingTrainingTreatment CostUniversitiesViralViral Load resultWomanantiretroviral therapybasecare deliverycohesioncollegecomparative effectivenessdesigneducation accesseffectiveness trialfollow-upimplementation sciencemotivational enhancement therapyprimary outcomeprogramsretention ratesecondary outcomeskillssocial stigmatrial design
中文摘要
描述(由申请人提供):在全球范围内,尼日利亚拥有第二大数量:a)艾滋病毒感染者,B)新的艾滋病毒感染者,c)感染艾滋病毒的孕妇。2013年,只有17.1%的15-49岁育龄妇女接受了艾滋病毒检测在尼日利亚估计有190 000名感染艾滋病毒的孕妇中,只有27%的孕妇接受了预防母婴传播艾滋病毒的抗逆转录病毒治疗,相比之下,撒哈拉以南非洲(SSA)接受抗逆转录病毒治疗的孕妇占68%。在21个重点国家中,尼日利亚占儿童艾滋病毒新感染的25%(估计有51 000例新感染)。在撒南非洲,大约49%的艾滋病毒感染孕妇在产前保健登记和分娩之间失去了后续行动,45%的婴儿在艾滋病毒检测后丢失。在尼日利亚,感染艾滋病毒的妇女和儿童中,失访率很高(15%-56%)。2014年,我们证明了健康开端倡议(HBI),一个由教会卫生团队提供的以教会为基础的干预措施,与以诊所为基础的方法相比,在增加孕妇艾滋病毒检测方面更有效。HBI利用教会组织的婴儿淋浴来参与和识别怀孕早期的妇女,将教育干预与综合的现场实验室测试相结合,旨在减少与艾滋病毒检测相关的耻辱感。婴儿接收便利了分娩后的后续行动和与护理的联系。HBI解决了艾滋病毒检测的几个障碍:感染风险低的观念(教育),获得检测和治疗的机会,以及费用和耻辱(现场,免费,综合检测)。每个社区至少有一个信仰机构,这为评估iSTAR的有效性提供了一个独特的机会,iSTAR是一种基于社区和诊所的综合干预措施,旨在检测、联系、吸引和维持接受护理的艾滋病毒感染妇女。我们提出了一个集群随机比较有效性试验的iSTAR与临床为基础的方法(CG)。我们将评估400名感染艾滋病毒的妇女之间的联系、参与、保留和病毒抑制。基于EPIS框架,我们将使用社会网络干预方法来促进实施,并评估实施领导和背景。尼日利亚南部的50个教会将被随机分配(1:1)到iSTAR或CG。iSTAR干预措施提供:在婴儿洗礼期间进行保密的现场综合实验室检测;教会保健顾问网络;接受过动机访谈培训的诊所小组;提高质量技能,以吸引和支持感染艾滋病毒的妇女;以及综合病例管理,以减少后续行动的损失。主要结局是iSTAR和CG之间的联系和参与率差异。次要结局是保留率和病毒抑制率的差异。该提案是以下机构合作提出的:尼日利亚大学(总统艾滋病紧急救援计划资助的尼日利亚合作伙伴[培训和地方项目监督])、南加州大学(网络分析)、加州大学圣地亚哥分校(实施科学)、国际学院芝加哥分校(可持续性评估)、内华达州州立学院(统计分析和调解/适度分析)以及内华达州、拉斯维加斯大学(全面监督方案实施和评价)。
英文摘要
DESCRIPTION (provided by applicant): Globally, Nigeria has the 2nd largest number of: a) people living with HIV, b) new HIV infections, and c) pregnant women living with HIV. In 2013 only 17.1% of women of childbearing age 15-49 years received an HIV test (preceding 12-months) and only 27% of the estimated 190,000 HIV-infected pregnant women in Nigeria who delivered babies received antiretroviral therapy for prevention of mother-to-child HIV transmission (PMTCT), compared to 68% of pregnant women receiving ART overall in sub-Saharan Africa (SSA). Nigeria accounts for 25% of new childhood HIV infections among the 21 priority countries (estimated 51,000 new infections). Roughly 49% of HIV-infected pregnant women in SSA are lost to follow up between registration in antenatal care and delivery, and 45% of infants are lost after HIV testing. Nigeria has high loss to follow-up (15%-56%) among HIV-infected women and children. In 2014, we demonstrated that the Healthy Beginning Initiative (HBI), a congregation-based intervention delivered by church-based health teams, was more effective in increasing HIV testing among pregnant women compared to a clinic-based approach. HBI uses church organized baby showers to engage and identify women early in pregnancy, combines educational intervention with integrated, on-site laboratory testing designed to reduce stigma associated with HIV-only testing. Baby receptions facilitate post-delivery follow-up and linkage to care. HBI addresses several barriers to HIV testing: perception of low risk to infection (education), access to testing and treatment, and cost and stigma (on-site, free, integrated testing). At least one faith-based institution is in each community, presenting a unique opportunity to evaluate the effectiveness of iSTAR, an integrated community and clinic based intervention that is designed to test, link, engage and sustain HIV-infected women in care. We propose a cluster randomized comparative effectiveness trial of iSTAR versus a clinic-based approach (CG). We will assess linkage, engagement, retention and viral suppression among 400 HIV-infected women. Based on the EPIS framework, we will use social network intervention methods to facilitate implementation and also assess implementation leadership and context. Fifty churches in south-south Nigeria will be randomly assigned (1:1) to iSTAR or CG. The iSTAR intervention provides: confidential, onsite integrated laboratory testing during baby showers; a network of church-based health advisors; clinic based teams trained in motivational interviewing; quality improvement skills to engage and support HIV-infected women; and integrated case management to reduce loss to follow-up. Primary outcomes are difference in linkage and engagement rates between iSTAR and CG. Secondary outcomes are difference in retention and viral suppression rate. This proposal is a collaboration among University of Nigeria (PEPFAR-funded partner in Nigeria [training and local project oversight]; University of Southern California (network analysis); UC San Diego (implementation science); UIC Chicago (assessment of sustainment); Nevada State College (statistical analyses and mediation/moderation analysis), and University of Nevada, Las Vegas (overall oversight of program implementation and evaluation).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Adolescent Coordinated Transition (ACT) to Improve Health Outcomes among Nigerian HIV Youth
-
批准号:9206425
-
项目类别:
-
资助金额:$30.61万
-
财政年份:2016
-
负责人:Echezona Edozie Ezeanolue
-
依托单位:
Point-of-Delivery Prenatal Test Results through mHealth to Improve Birth Outcome
-
批准号:9020158
-
项目类别:
-
资助金额:$15.67万
-
财政年份:2015
-
负责人:Echezona Edozie Ezeanolue
-
依托单位:
Point-of-Delivery Prenatal Test Results through mHealth to Improve Birth Outcome
-
批准号:9149340
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2015
-
负责人:Echezona Edozie Ezeanolue
-
依托单位:
Comparative Effectiveness of Congregation and Clinic Based Approaches to PMTCT
-
批准号:8551683
-
项目类别:
-
资助金额:$44.48万
-
财政年份:2012
-
负责人:Echezona Edozie Ezeanolue
-
依托单位:
Comparative Effectiveness of Congregation and Clinic Based Approaches to PMTCT
-
批准号:8433153
-
项目类别:
-
资助金额:$44.85万
-
财政年份:2012
-
负责人:Echezona Edozie Ezeanolue
-
依托单位:
Comparative Effectiveness of Congregation and Clinic Based Approaches to PMTCT
-
批准号:8879485
-
项目类别:
-
资助金额:$44.87万
-
财政年份:2012
-
负责人:Echezona Edozie Ezeanolue
-
依托单位:
海外基金